Noninvasive blood glucose measurement method and apparatus
A blood glucose measurement apparatus includes: a control unit configured to determine a user's blood glucose level based on a concentration of body fluid secreted from the user; and a biometric information acquisition unit configured to acquire biometric information indicating a status of a user's autonomic nervous system. The control unit is configured to correct the determined blood glucose level based on the biometric information.
1. A blood glucose measurement apparatus comprising:
a processor configured to:
determine a user's blood glucose level in a non-invasive manner based on a concentration of body fluid secreted from the user, without needing a blood sample from the user,
correct the determined user's blood glucose level based on biometric information obtained from the user indicating a status of the user's autonomic nervous system, wherein the biometric information indicating the status of the autonomic nervous system includes at least one of a user's heart rate, a user's galvanic skin response, a contraction degree of a user's blood vessel, a size of a user's pupil, an amount of a user's tear, an amount of a user's saliva, and a user's body temperature, and
wherein the body fluid includes at least one of a user's sweat, tear, saliva, and urine.
2. The blood glucose measurement apparatus of claim 1 , wherein the processor is configured to determine the status of the autonomic nervous system based on the biometric information, determine a secretion velocity of the body fluid based on the determined status of the autonomic nervous system, and correct the determined user's blood glucose level based on the determined secretion velocity of the body fluid.
3. The blood glucose measurement apparatus of claim 1 , wherein the status of the autonomic nervous system includes an activity degree of at least one of a user's sympathetic nerve and parasympathetic nerve.
4. The blood glucose measurement apparatus of claim 1 , comprising a communication unit comprising a WiFi chip, NFC chip, Bluetooth chip, and/or wireless communication chip, configured to receive the biometric information indicating the status of the user's autonomic nervous system from a sensor attached to the user.
5. The blood glucose measurement apparatus comprising: of claim 4 ,
wherein the processor is further configured to determine a user's blood glucose level based on a concentration of biomarker gas in an expiration of the user,
wherein the communication unit is further configured to receive biometric information indicating a motion quantity of the user,
wherein the processor is further configured to correct the determined user's blood glucose level based on the biometric information indicating the user's motion quantity.
6. The blood glucose measurement apparatus of claim 5 , wherein the biomarker gas is a gas that is discharged through the user's expiration when a user's body fat is decomposed.
7. The blood glucose measurement apparatus of claim 5 , wherein the biometric information indicating the user's motion quantity comprises at least one of a user's step count, a user's moving speed, a user's heart rate, a users' skin hydration, and a user's body temperature.
8. The blood glucose measurement apparatus of claim 5 , wherein the processor is configured to determine a user's motion quantity per unit time based on the biometric information and correct the determined user's blood glucose level based on the determined motion quantity per unit time.
9. A blood glucose measurement method comprising:
determining a user's blood glucose level in a non-invasive manner based on a concentration of body fluid secreted from the user, without needing a blood sample from the user;
acquiring biometric information indicating a status of the user's autonomic nervous system; and
correcting the determined user's blood glucose level based on the biometric information obtained from the user indicating a status of the user's autonomic nervous system, wherein the biometric information indicating the status of the autonomic nervous system includes at least one of a user's heart rate, a user's galvanic skin response, a contraction degree of a user's blood vessel, a size of a user's pupil, an amount of a user's tear, an amount of a user's saliva, and a user's body temperature,
wherein the body fluid includes at least one of a user's sweat, tear, saliva, and urine;
wherein the blood glucose measurement method further comprises: updating a blood glucose measurement algorithm using a corrected blood glucose measurement algorithm received from a server, wherein the corrected blood glucose measurement algorithm is corrected based on information related to the user's health.
10. The blood glucose measurement method of claim 9 , wherein the correcting of the determined user's blood glucose level based on the biometric information comprises:
determining the status of the autonomic nervous system based on the biometric information;
determining a secretion velocity of the body fluid based on the determined status of the autonomic nervous system; and
correcting the determined user's blood glucose level based on the determined secretion velocity of the body fluid.
11. The blood glucose measurement method of claim 9 , wherein the status of the autonomic nervous system includes an activity degree of at least one of a user's sympathetic nerve and parasympathetic nerve.
12. The blood glucose measurement method of claim 9 , wherein the acquiring of the biometric information indicating the status of the user's autonomic nervous system comprises receiving the biometric information indicating the status of the user's autonomic nervous system from a sensor attached to the user.
13. The blood glucose measurement method of claim 9 , further comprising:
determining the user's blood glucose level based on a concentration of biomarker gas in an expiration of the user;
acquiring biometric information indicating a motion quantity of the user; and
correcting the determined user's blood glucose level based on the biometric information.
14. The blood glucose measurement method of claim 13 , wherein the biomarker gas is a gas that is discharged through the user's expiration when a user's body fat is decomposed.
15. The blood glucose measurement method of claim 13 , wherein the biometric information indicating the user's motion quantity comprises at least one of a user's step count, a user's moving speed, a user's heart rate, a user's skin hydration, and a user's body temperature.
16. The blood glucose measurement method of claim 13 , wherein the correcting of the determined user's blood glucose level based on the biometric information comprises:
determining the user's motion quantity per unit time based on the biometric information; and
correcting the determined blood glucose level based on the determined motion quantity per unit time.